Objectives: Signaling in adenosine-mediated preconditioning is controversial. We examined roles of mitochondrial (mito) K ATP channels, protein kinase C (PKC) and nitric oxide (NO). Methods: Langendorff perfused C57 / Bl6 mouse hearts were subjected to 20 min ischemia and 45 min reperfusion. Effects of adenosine-mediated preconditioning were assessed in the absence and presence of signaling inhibitors. Results: Control hearts recovered 7062 mmHg ventricular pressure, and released 18.162.0 IU / g lactate dehydrogenase (LDH). Preconditioning with 10 mM adenosine limited necrosis (10.661.4 IU / g) without modifying contractility (7262 mmHg) whereas 50 mM adenosine reduced necrosis (10.361.6 IU / g) and contractile dysfunction (9162 mmHg). All protective effects of 10 and 50 mM adenosine were abrogated by mito K channel blockade with 100 mM 5-hydroxydecanoate (5-HD) during the 'trigger' ATP G phase, but unaltered by PKC or NO synthase inhibition with 3 mM chelerythrine or 100 mM N -nitro-L-arginine methyl ester (L-NAME), respectively. Protection against necrosis was eliminated by 5-HD but unaltered by chelerythrine or L-NAME during the 'mediation' phase (ischemia-reperfusion). Reduced contractile dysfunction with 50 mM adenosine was partially sensitive to 5-HD and chelerythrine, and only eliminated by co-infusion of the inhibitors. Conclusions: Adenosine-mediated preconditioning is dose-dependent with high level stimulation reducing contractile dysfunction in addition to necrosis. Preconditioning is triggered by a mito K channel dependent ATP process independently of PKC and NO. Subsequent protection against necrosis is also mediated by a mito K channel dependent ATP process independent of PKC and NO. In contrast, functional protection may be mediated by parallel mito K and PKC dependent paths.
. Introduction
Downey and colleagues [5, 6 ] present a scheme whereby preconditioning stimuli activate multiple paths converging Mechanisms of adenosine-mediated cardioprotection on PKC and / or radical generation. However, the function remain controversial. Investigations implicate mito K of PKC is also controversial, with evidence for [9,10] and ATP channels as downstream mediators of cardioprotective against [11, 12] an essential role in cardioprotection, opposstimuli including preconditioning [1, 2] and adenosine ing data regarding location downstream [13] vs. upstream [3, 4] . However, adenosine-mediated preconditioning was [14] of mito K channels, and evidence adenosine may ATP recently found to be mito K independent, in contrast to inhibit rather than activate PKC in ischemic myocardium ATP other G-coupled stimuli [5] . Furthermore, there is evidence [15] . The importance of endogenous NO is also unclear, mito K channels are uninvolved in ischemic precondiwith evidence for [16, 17] and against [18, 19] a role in ATP tioning [6] , contrasting data supporting obligatory roles for early preconditioning, and for [20] and against [21] a role mito K channels prior to and during ischemia [1, 2, 7, 8] . in adenosine-mediated protection. There is even evidence ATP NO worsens ischemic injury via an adenosine-dependent mechanism [18] .
These uncertainties may reflect multiple signaling paths repeated in hearts receiving 100 mM 5-HD, 3 mM in preconditioning [22, 23] , providing 'redundancy'. It is chelerythrine, or 100 mM L-NAME initiated 2.5 min prior also possible different paths may mediate differing protecto adenosine infusion and terminated 2.5 min after infutive effects. There is evidence for disparate signaling in sion. To examine signaling during the mediation phase anti-necrotic vs. anti-stunning [24, 25] or anti-arrhythmic (ischemia-reperfusion), preconditioned hearts were treated [26] effects of preconditioning. The aim of the present with 100 mM 5-HD (n58 and 9 for 10 and 50 mM study was to test the hypothesis that adenosine-mediated adenosine, respectively), 3 mM chelerythrine, 100 mM preconditioning involves multiple signaling pathways, 5-HD plus 3 mM chelerythrine, 100 mM L-NAME, or 100 potentially involving mito K channels, PKC, and NO. mM 5-HD plus 100 mM L-NAME initiated 5 min after ATP adenosine infusion and maintained for the duration of the experiment. Inhibitors were also infused for the same 2 . Methods periods in non-preconditioned hearts.
To confirm inhibitory effects of 5-HD, and ability to 2 .1. Perfused heart preparation precondition via mito K channel activation, we ex-ATP amined effects of 5 min stimulation with 50 mM diazoxide Experiments were performed in accordance with the followed by 10 min washout prior to 20 min ischemia. Guide for the Care and Use of Laboratory Animals (NIH This was repeated with 100 mM 5-HD bracketing diazoxPublication No. 85-23, revised 1996), and work approved ide infusion or during ischemia-reperfusion. Finally, efby the Institutional Animal Care and Use committee. The fects of post-ischemic supplementation with 40 mM Langendorff mouse heart model described previously was inosine130 mM hypoxanthine120 mM xanthine was employed [27, 28] . Hearts were isolated from 16 to 20-examined in control hearts, and hearts preconditioned with week-old male C57 / Bl6 mice (body weight523.660.4 g, 50 mM adenosine. Levels of substrate are based on n5333) anesthetized with 50 mg / kg sodium pentobarbital interstitial estimates from microdialysis studies of ischemic administered intraperitoneally. After a thoracotomy, hearts myocardium [28] . The substrate mix was infused throughwere excised into ice-cold perfusion buffer, the aorta out reperfusion. cannulated (20 gauge stainless steel) and perfused at 80
Inhibitory effects of L-NAME were confirmed in premmHg with Krebs buffer containing (mM): NaCl, 118;
liminary experiments in which dilatory responses to an NaHCO , 25; KCl, 4.7; KH PO , 1.2; CaCl , 2.5;
A adenosine receptor agonist (with 1 nM CGS21680) (IU / g) was determined by multiplying concentration (IU / ml) by effluent volume (ml / g). Hearts stabilized for 10 min at intrinsic heart rate were
In separate experiments, the relation between infarct size switched to pacing at 420 beats / min (ventricular pacing, 2 and LDH efflux was assessed for hearts reperfused for 45 ms duration, 20% above threshold) for 20 min. Baseline min after 25 min ischemia, 20 min ischemia, or 20 min function was assessed and 20 min global ischemia initiated ischemia with preconditioning with 10 or 50 mM adenofollowed by 45 min reperfusion. Pacing was stopped sine, 50 mM adenosine in the presence of either 5-HD or during ischemia and re-instated at 2 min reperfusion chelerythrine during ischemia-reperfusion. Infarct size [4, 27, 28] . The protocol is outlined in Fig. 1 . Hearts were was assessed as described previously [29] . On completion untreated or subjected to preconditioning stimuli in the of experiments 8 ml of 1% (w / v) TTC in PBS was infused absence or presence of varied inhibitors. Preconditioning at a pressure of 100 mmHg. Hearts were removed from the response to 10 or 50 mM adenosine were assessed by cannula, weighed and fixed overnight in 10% formalin. infusion for 5 min followed by 10 min washout prior to Fixed hearts were stored at 220 8C until sectioned transischemia. To examine signal transduction during the versely. The 0.5-mm sections were placed between microtrigger phase (preconditioning stimulus), experiments were scope slides and visualized using a computer imaging system. Boundaries of infarct area (TTC negative) were stock solution was prepared by initially dissolving the drug traced in each slice, and areas determined digitally by in a small volume of 0.1 N NaOH and subsequently computer-assisted planimetry. Infarct size per section was diluting in water. All drug solutions were infused at 1% of expressed as % of area at risk (sum of total ventricular area coronary flow to achieve the final concentrations indicated. minus cavities). Infarct size was averaged from five sections.
2 .5. Statistical analysis
.4. Drugs
Data are presented as mean6S.E.M. Baseline data and post-ischemic functional recoveries and enzyme effluxes in Drugs were purchased from Sigma / RBI (Castle Hill, different experimental groups were analyzed by one-way Australia). Adenosine, chelerythrine, 5-HD, and L-NAME ANOVA with Tukey's post-hoc test. A value of P,0.05 were all prepared daily in distilled water. For diazoxide, a was considered significant. 
. Results

.3. Signaling involved in triggering and mediating antinecrotic and functional effects of adenosine-mediated .1. Normoxic function preconditioning
Baseline functional data are provided in Table 1 .
The reduction in LDH efflux in preconditioned hearts Pressure development, and inotropic and lusitropic states was abolished by 5-HD during either the trigger (adenosine were high, and coronary flow sub-maximal [27] . No treatment period) or mediation (subsequent ischemia-redifferences in pre-ischemic contractile function were deperfusion) periods ( Fig. 2A) . In contrast, neither tected between untreated hearts and hearts treated with chelerythrine or L-NAME modified necrosis when supplied inhibitors or pharmacologically preconditioned with adenoduring the trigger or mediation phases ( Fig. 2B and C). sine or diazoxide (Table 1 , Fig. 2 ).
Effects of signaling inhibitors on functional recoveries did not mirror effects on necrosis. Again, 5-HD during the 3 .2. Responses to ischemia-reperfusion and adenosinetrigger phase abrogated functional protection with premediated preconditioning conditioning (Fig. 3) . However, 5-HD during the mediation phase only partially limited functional protection. Ischemia-reperfusion induced significant necrosis, as While chelerythrine during the trigger phase failed to alter assessed by post-ischemic efflux of LDH. Untreated hearts functional recoveries, chelerythrine during the mediation released |18 IU / g LDH into the venous effluent over the phase also partially limited functional protection (Fig. 4 ).
45-min reperfusion period (Fig. 2) which is |10-fold
Inhibition of NO synthase with L-NAME during either higher than efflux of LDH in normoxic hearts (calculated phase did not modify functional recoveries (Fig. 5 ). While to be 1.960.4 IU / g over a 45-min perfusion period).
neither 5-HD or chelerythrine alone abolished functional Preconditioning with 10 and 50 mM adenosine resulted in protection, co-treatment with 5-HD plus chelerythrine substantial and almost identical reductions in post-ischemic during the mediation phase effectively abrogated protec-LDH efflux (Fig. 2) . tion with 50 mM adenosine (Fig. 6 ). Co-treatment with In addition to necrosis, ischemia resulted in a sustained 5-HD plus L-NAME was no more effective than 5-HD depression of contractile function during 45 min reperfualone (Fig. 6 ). sion. Diastolic pressure remained elevated at |22 mmHg (Fig. 3A) , and ventricular pressure development recovered 3 .4. Effects of mito K channel activation and ATP to |50% of pre-ischemic levels (Fig. 3B ). Coronary flow adenosine catabolites recovered to slightly less than pre-ischemic levels (Fig.  3C) . Preconditioning with 50 mM adenosine significantly Pre-treatment with the putative mito K opener ATP improved recovery of diastolic and developed pressures diazoxide induced a preconditioning response (Fig. 7 ). whereas preconditioning with 10 mM adenosine exerted a Effects of diazoxide were largely restricted to reduced modest effect on diastolic pressure and no effect on overall necrosis, with modest effects on contractile function. pressure development. Coronary reflow was not altered by Protection was eliminated by 5-HD during both trigger and 10 mM adenosine but was significantly enhanced by mediation phases (Fig. 7) . Supplying hearts with elevated preconditioning with 50 mM adenosine (Fig. 3C) .
inosine, hypoxanthine and xanthine during reperfusion inhibition (C) during trigger or mediation phases. Post-ischemic LDH efflux was determined in non-preconditioned hearts and hearts preconditioned with 10 or 50 mM adenosine. Hearts were untreated, or treated with 100 mM 5-HD, 3 mM chelerythrine (Chel), or 100 mM L-NAME during the adenosine † stimulus or subsequent ischemia-reperfusion. Values are means6S.E.M. * P,0.05 vs. corresponding values from the non-preconditioned group; P,0.05 vs. untreated hearts within the same group. 50 mM adenosine whereas contractile recoveries differed substantially. Treatment of 50 mM adenosine preconfailed to alter ischemic tolerance (in terms of necrosis or ditioned hearts with 5-HD abolished effects on infarction functional recovery) in non-preconditioned or precon-(to control levels) but did not eliminate functional protecditioned hearts (Fig. 8) .
tion.
.5. Relationships between infarct size, LDH efflux, and functional recovery 4 . Discussion
Data in Fig. 9 depict relationships between infarct size, Our primary goal was to test whether adenosine-mepost-ischemic LDH efflux and functional recovery. A diated preconditioning involves multiple signaling pathlinear correlation was obtained between infarct size and ways. Data reveal ischemic tolerance in murine hearts is LDH efflux (Fig. 9A) . The same patterns of changes were enhanced by pre-treatment with adenosine, and this is observed with LDH efflux and infarct size: preconditioning triggered by a mito K channel dependent process ATP with 10 and 50 mM adenosine comparably reduced both independently of PKC or NO. Subsequent mediation of measures, 5-HD during ischemia-reperfusion eliminated anti-necrotic effects during ischemia-reperfusion also reeffects of adenosine on infarction while chelerythrine was quires mito K channel activity. However, protection ATP ineffective. A longer period of ischemia (25 min) exaggeragainst contractile dysfunction with high level adenosine ated LDH efflux and infarction proportionately. In terms of appears mediated by parallel mito K channel and PKC ATP functional recovery, there was a general linear relation dependent paths. between infarct size and post-ischemic diastolic dysfunction (Fig. 9B) . However, recovery of developed pressure 4 .1. Adenosine-mediated preconditioning was not consistently linked to infarct size (Fig. 9C) . Infarction was similar in hearts preconditioned with 10 and Adenosine pre-treatment in mouse hearts enhanced ischemic tolerance (Figs. 2 and 3) , and the type of protection was dependent upon adenosine concentration employed: 10 and 50 mM adenosine equally limit necrosis whereas only 50 mM adenosine reduced contractile dysfunction (Figs. 2 and 3 ). This concentration dependence may stem from differing activation of receptor sub-types. Adenosine has a 10-fold higher affinity for A vs. A 1 3
receptors [30] , and these receptors couple to different activation of A receptors is therefore predicted in the 3 10-mM group [30] , whereas both sub-types will be maximally active in the 50-mM group. It is possible high affinity A receptors preferentially limit necrosis while less 4 . [36] , also in rabbit. Reasons for these murine model does not have the capacity to be acutely discrepancies are unclear, but may involve the stimuli or preconditioned via NO or PKC dependent paths. However, antagonists employed. We examine adenosine-mediated a number of murine studies reveal this is not the case. protection, shown by Cohen et al.
[5] to possess a Specific stimuli such as resveratol elicit acute NO-depensignaling path differing from other G-coupled stimuli, and dent protection [39] , and transgenic modulation of PKC the lack of effect of chelerythrine is consistent with signaling enhances ischemic tolerance [40] in mouse. observations regarding chelerythrine and staurosporine in Thus, acute NO and PKC mediated protection occur in this diazoxide-mediated preconditioning [6, 36] . species. Our data regarding lack of effect of NO and PKC inhibition are consistent with findings in eNOS knockout 4 .3. Signaling involved in mediating protection in mice demonstrating no obligatory role for NO in ischemic preconditioned hearts preconditioning [17] , and partially consistent with the observation PKC knockout abrogates anti-necrotic but not In terms of protection during ischemia-reperfusion, data functional effects of ischemic preconditioning [41] . again support a role for mito K channels (Figs. 2 and   ATP 3). However, 5-HD during mediation did not eliminate 4 .5. Dissociation of contractile recovery from necrosis protection against contractile dysfunction (Fig. 3) . Furthermore, in contrast to lack of effect during the trigger phase, As indicated, functional recovery is dissociated from chelerythrine during ischemia-reperfusion reduced funcnecrosis in selected groups. While 10 and 50 mM adenotional protection (Figs. 2 and 4) . Since co-infusion of sine equally limit LDH efflux and infarct size (Figs. 2 and 5-HD and chelerythrine abrogated protection (Fig. 6) , 9), only 50 mM adenosine improved contractility ( recovery and necrosis has been noted recently for preThe current findings agree with prior studies questioning conditioned hearts [35, 41] , and in earlier studies [42] , and the role of PKC in preconditioning [11, 12] , and supporting is verified here by measurement of infarct size (Fig. 9) . multiple signaling paths [22, 23] . Our data also agree with
These data indicate functional effects of 50 mM adenosine findings of Toyoda et al. [24] , who showed adenosineare distinct from necrosis, and are mediated by combined enhanced ischemic preconditioning reduces necrosis via a mito K channel and PKC dependent processes. Data in ATP mito K channel dependent process whereas anti-stun- Fig. 9 show a weak correlation between contractile re-ATP ning effects involve other paths. Other studies support covery and infarction in non-preconditioned vs. preconmultiple signaling mechanisms for protective stimuli. For ditioned hearts. Interestingly, diastolic pressure is more example, opioid-mediated preconditioning against necrosis consistently correlated with necrosis than pressure deis PKC-dependent whereas protection against arvelopment, suggesting a greater dependence of diastolic rhythmogenesis is not [26] . Clearly, the notion of a stiffness on infarct size. common path of preconditioning converging on PKC [5, 6] Selective inhibition of oxidant damage may modify is not applicable to different stimuli or differing endcontractility independently of necrosis [42] . Since points.
adenosine-mediated preconditioning limits oxidant stress via a mito K and PKC dependent path [43] , this could ATP 4 .4. NO and adenosine-mediated preconditioning selectively reduce stunning. Additionally, reduced oxidant stress could occur via reduced xanthine-oxidase derived Endogenous NO is implicated in acute ischemic preradical formation, since preconditioning limits substrate conditioning [16, 17] and adenosine-mediated protection delivery to this enzyme. The putative xanthine oxidase [20] . Nonetheless, there is evidence NO plays no role in inhibitor allopurinol enhances post-ischemic function in these situations [19, 21] . Our data support the latter obcontrol but not preconditioned hearts [44] . We examined servations, demonstrating that a level of L-NAME suffithis possibility by supplementation with purine metabocient to eliminate dilatory responses to A agonism and lites, reasoning that if contractile recovery was sensitive to 2 ADP fails to alter protection with adenosine (Figs. 2 and xanthine-oxidase [44] , exogenous substrate should modify 5). The inhibitor also failed to augment effects of 5-HD recovery. As shown in Fig. 8 , purine substrates did not (Fig. 6) . We conclude NO plays no obligatory role in acute alter functional recovery in control or preconditioned hearts, inconsistent with selective effects of xanthine-oxiNational Heart Foundation of Australia (G 98B 0080 and dase derived radicals on contractility [42, 44] . As discussed G 99B 0246). John Headrick was the recipient of a career previously [45] , the xanthine-oxidase reaction should be fellowship from the National Heart Foundation of Aussubstrate saturated during ischemia and early reperfusion, tralia. and even a 2-fold reduction in substrate is unlikely to limit oxidant formation. Furthermore, uric acid formed exerts beneficial anti-oxidant effects [46] . Recent observations of Gelpi et al. [44] may reflect other effects of allopurinol, R eferences which protects in xanthine-oxidase deficient species [47, 48] previous work [29] . Importantly, key changes in infarct specifically support our major conclusions. tinct from anti-necrotic effects. This protection appears Collectively, our data support signaling paths for contractility. 
